2-[(2S)-5,5-dimethylmorpholin-2-yl]acetic acid
Structure Info
- Chemspace ID
- CSSS00015321027 (In-Stock Screening Compounds)
- MFCD
- MFCD05662362, MFCD00274190, MFCD30156460
- IUPAC Name
- 2-[(2S)-5,5-dimethylmorpholin-2-yl]acetic acid
- Mol formula
- C8H15NO3
- Mol weight
- 173 Da
- Catalog Number(s)
- 160415-07-6, 53R0102, 53R0291, AA01ENOZ, ACM160415076, AG01ENRR, AGNPC-0O4KUI, AKOS006281395, AKOS042345077, AR01EOGR, AX63407, ArZ-UP132156, ArZ-UP377705, ArZ-UP377795, ArZ-UP505221, BBLS00015321027, BBV-38271021, BD01195216, CSC015321027, D705017, EC01EPXJ, FCH835240, HY-12783A, JH163620, K38098, MS-33235, OR1114655, S200045, ST01EP8J, T12867L, TX01EOXF, Y1127880, Y1127973, Y3259708, ZXC101279, ZXC150841, ZXC150931, ZXC220854, ZXC364257, bbls00015321027
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -2.41
- Heavy atoms count
- 12
- Rotatable bond count
- 2
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.875
- Polar surface area (Å)
- 59
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 2
![Chemical structure of 2-[(2S)-5,5-dimethylmorpholin-2-yl]acetic acid (C8H15NO3) - CSSS00015321027](/st/structure/200/99255a8680f3e0388a2215379a3d36f5/CC1%2528C%2529CO%255BC%2540%2540H%255D%2528CC%2528O%2529%253DO%2529CN1.png "C8H15NO3")
- Zoom the structure
- CSSS00015321027
Items Overall 10 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | 10 days | United States To: | 99 | 5 mg | 150.00 | |
| MedChemExpress | 10 days | United States To: | 99 | 10 mg | 250.00 | |
| MedChemExpress | 10 days | United States To: | 99 | 25 mg | 560.00 | |
| MedChemExpress | 10 days | United States To: | 99 | 50 mg | 950.00 | |
| MedChemExpress | 10 days | United States To: | 99 | 1 ml | 165.00 | |
Description: Names: SCH 50911; Product Description: SCH 50911 is a selective, orally active, blood-brain barrier permeable GABA-B receptor (GABA-B Receptor) antagonist with an IC50 of 1.1 μM in rats. SCH 50911 blocks baclofen-induced antitussive effects, regulates neuronal firing and GABA release. SCH 50911 promotes spontaneous seizures during withdrawal in ethanol-dependent rats, alters reward-related neurotransmission, and reduces or suppresses lever responding and self-administration behaviors of alcohol and sucrose in rats. SCH 50911 is applicable to research related to ethanol withdrawal syndrome, absence epilepsy and alcohol use disorder; Target: GABA Receptor; CAS: 733717-87-8 | ||||||
| MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 150.00 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 250.00 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 560.00 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 950.00 | |
| MedChemExpress EU | 10 days | Sweden To: | 99 | 1 ml | 165.00 | |
Description: Names: SCH 50911; Product Description: SCH 50911 is a selective, orally active, blood-brain barrier permeable GABA-B receptor (GABA-B Receptor) antagonist with an IC50 of 1.1 μM in rats. SCH 50911 blocks baclofen-induced antitussive effects, regulates neuronal firing and GABA release. SCH 50911 promotes spontaneous seizures during withdrawal in ethanol-dependent rats, alters reward-related neurotransmission, and reduces or suppresses lever responding and self-administration behaviors of alcohol and sucrose in rats. SCH 50911 is applicable to research related to ethanol withdrawal syndrome, absence epilepsy and alcohol use disorder; Target: GABA Receptor; CAS: 733717-87-8 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire